Anzeige
Mehr »
Mittwoch, 15.04.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JLYP | ISIN: KYG211081248 | Ticker-Symbol: 2M7C
Tradegate
10.04.26 | 09:31
1,530 Euro
-0,65 % -0,010
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD Chart 1 Jahr
5-Tage-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,5301,60009:15
1,5401,59009:16

Aktuelle News zur CHINA MEDICAL SYSTEM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
01.04.CMS (00867): FORM OF PROXY-
01.04.CMS (00867): NOTICE OF ANNUAL GENERAL MEETING-
01.04.CMS (00867): PROPOSALS FOR (1) RE-ELECTION OF THE RETIRING DIRECTORS (2) DECLARATION OF FINAL DIVIDEND (3) GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE ...-
CHINA MEDICAL SYSTEM Aktie jetzt für 0€ handeln
01.04.CMS (00867): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025-
01.04.CMS (00867): ANNUAL REPORT 2025-
17.03.CMS (00867): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE2
17.03.CMS (00867): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION1
17.03.CMS (00867): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 20251
16.03.China Medical System Holdings Limited Full Year Income Falls1
16.03.CMS (00867): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025 AND CHANGE OF MEMBER OF THE ENVIRONMENTAL, SOCIAL AND GOVERNANCE COMMITTEE1
13.03.China Medical System Holdings Ltd.: CMS(867.HK/8A8.SG): New Drug for Renal Anaemia Desidustat Tablets Approved in China2
13.03.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT NEW DRUG FOR RENAL ANAEMIA DESIDUSTAT TABLETS APPROVED IN CHINA1
13.03.China Medical System Holdings Ltd.: CMS(867.HK/8A8.SG):Ruxolitinib Phosphate Cream (Lumirix) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo1
05.03.China Medical System Holdings Ltd.: CMS(867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity1
04.03.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT APPROVAL OF DRUG CLINICAL TRIALS FOR OVERWEIGHT/OBESITY INDICATION OF SELF-DEVELOPED INNOVATIVE ...-
04.03.CMS (00867): NOTICE OF BOARD MEETING2
24.02.China Medical System Holdings Ltd.: CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China1
24.02.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT NEW DRUG APPLICATION FOR ADDITIONAL INDICATION ATOPIC DERMATITIS (AD) FOR RUXOLITINIB PHOSPHATE ...-
12.02.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT SIGNING OF EXCLUSIVE DISTRIBUTION AGREEMENT FOR THE ORIGINAL DRUG LIDODERM LIDOCAINE CATAPLASMS3
03.02.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT APPROVAL OF DRUG CLINICAL TRIALS FOR COMPLEMENT - MEDIATED KIDNEY DISEASE INDICATION OF INNOVATIVE ...3
Weiter >>
40 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1